Related Experiment Video
Updated: Jan 13, 2026

Extraction and Purification of Polyphenols from Freeze-dried Berry Powder for the Treatment of Vascular Smooth Muscle Cells In Vitro
Published on: July 5, 2017
Navigating the Effects of Anti-Atherosclerotic Supplements and Acknowledging Associated Bleeding Risks
Maria-Zinaida Dobre1, Bogdana Virgolici1, Ioana-Cristina Doicin2
1Department of Biochemistry, Faculty of Medicine, Carol Davila University of Medicine and Pharmacy, 050474 Bucharest, Romania.
Nutraceuticals like omega-3s and antioxidants show cardiovascular benefits but carry risks. Individualized use and more trials are needed to confirm safety and efficacy for heart health.
Area of Science:
- Cardiovascular Science
- Nutraceutical Research
- Integrative Medicine
Background:
- Nutraceuticals are increasingly explored for cardiovascular benefits.
- Mechanisms include lipid-lowering, antithrombotic, and vascular protective effects.
- Existing evidence varies, necessitating careful consideration of product quality and patient factors.
Purpose of the Study:
- To review the cardiovascular benefits of various nutraceuticals.
- To identify potential risks and limitations associated with their use.
- To emphasize the need for individualized treatment and further clinical research.
Main Methods:
- Literature review of studies on nutraceuticals and cardiovascular health.
- Analysis of mechanisms of action, including lipid metabolism, thrombosis, and vascular protection.
- Assessment of potential adverse effects, drug interactions, and bleeding risks.
Main Results:
- Omega-3 fatty acids, berberine, garlic, and nattokinase show promise for metabolic and vascular health.
- Antioxidants (vitamins C, E, resveratrol, astaxanthin, CoQ10) offer vascular protection but may affect hemostasis and metabolism.
- Herbal agents (ginkgo, ginger, ginseng, curcumin) possess anti-inflammatory properties but can increase bleeding risk with anticoagulants.
Conclusions:
- Nutraceuticals present potential cardiovascular advantages but require individualized application due to variable efficacy and safety profiles.
- Risks such as bleeding and drug interactions necessitate cautious use, especially with antithrombotic therapies.
- Large-scale clinical trials are essential to establish definitive safety and efficacy for widespread adoption in cardiovascular care.
Related Concept Videos
Atherosclerosis III: Management
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Peripheral Artery Disease III: Interprofessional Care
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Venous Thrombosis IV: Nursing Management